| Identification | |
| Name: | riluzole |
| Synonyms: | 2-Amino-6-(trifluoromethoxy)benzothiazole |
| CAS: | 1744-22-5 |
| Molecular Formula: | C8H5F3N2OS |
| Molecular Weight: | 234.19831 |
| InChI: | InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13) |
| Molecular Structure: |  |
| Properties | |
| Transport: | UN 2811 |
| Flash Point: | 133 ºC |
| Boiling Point: | 296.3 ºC at 760 mmHg |
| Density: | 1.572 g/cm3 |
| Appearance: | Powder. |
| Specification: | White Crystalline Solid usageEng:A neuroprotective agent. A glutamate release inhibitor. An anticonvulsant Safety Statements:45 45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) |
| Biological Activity: | Novel psychotropic agent with anticonvulsant, hypnotic, anxiolytic, anti-ischemic and anesthetic properties. Riluzole is able to act as a glutamate release inhibitor, blocks voltage-dependent Na + channels and inhibits GABA uptake by striatal synaptosomes. |
| Flash Point: | 133 ºC |
| Storage Temperature: | Store at room temperature in a tightly sealed container. |
| Color: | white |
| Usage: | A neuroprotective agent. A glutamate release inhibitor. An anticonvulsant |
| Safety Data | |
| Hazard Symbols |
T:Toxic
|
 |
|
